Increasing Midwifery Students' Awareness of Breast and Gynecological Cancers Using Creative Drama Method

NCT07073599 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-07-18

No results posted yet for this study

Summary

The aim of this study is to raise awareness among midwifery students, who are a part of the female population and a professional group that plays a critical role in the early diagnosis of these types of cancer, which are of critical importance for women's health, through an active education method such as drama.

Conditions

  • Creative Drama

Interventions

OTHER

Creative Drama Education

This study is a pre-test/post-test controlled experimental design aimed at evaluating the effectiveness of creative drama education on awareness of breast and gynecological cancers. Students in the intervention group will receive creative drama-based training structured and implemented by the researcher. This training is designed to increase awareness of breast and gynecological cancers. The effectiveness of the training will be assessed by comparing participants' awareness levels before and after the intervention. For this purpose, the following data collection tools will be used: Personal Information Form Breast Cancer Awareness Scale Gynecological Cancers Awareness Scale The impact of the creative drama education on the awareness levels of students in the intervention group regarding breast and gynecological cancers will be evaluated through statistical analysis.

Sponsors & Collaborators

  • Ataturk University

    lead OTHER

Principal Investigators

  • Zülbiye DEMİR BARBAK, 1 · Ataturk University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-01
Primary Completion
2025-11-01
Completion
2026-02-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07073599 on ClinicalTrials.gov